Page last updated: 2024-10-31

nabumetone and Arthritis, Juvenile Chronic

nabumetone has been researched along with Arthritis, Juvenile Chronic in 1 studies

Nabumetone: A butanone non-steroidal anti-inflammatory drug and cyclooxygenase-2 (COX2) inhibitor that is used in the management of pain associated with OSTEOARTHRITIS and RHEUMATOID ARTHRITIS.
nabumetone : A methyl ketone that is 2-butanone in which one of the methyl hydrogens at position 4 is replaced by a 6-methoxy-2-naphthyl group. A prodrug that is converted to the active metabolite, 6-methoxy-2-naphthylacetic acid, following oral administration. It is shown to have a slightly lower risk of gastrointestinal side effects than most other non-steroidal anti-inflammatory drugs.

Research Excerpts

ExcerptRelevanceReference
"Once-a-day dosing with nabumetone has been shown to be effective in adults with rheumatoid arthritis."2.71An open label study to establish dosing recommendations for nabumetone in juvenile rheumatoid arthritis. ( Flavin, S; Goodman, S; Haig, A; Howard, P; Macdonald, B, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goodman, S1
Howard, P1
Haig, A1
Flavin, S1
Macdonald, B1

Trials

1 trial available for nabumetone and Arthritis, Juvenile Chronic

ArticleYear
An open label study to establish dosing recommendations for nabumetone in juvenile rheumatoid arthritis.
    The Journal of rheumatology, 2003, Volume: 30, Issue:4

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Butanones; Child; Child, P

2003